Stock screener
All disclosures →
EDGAR →
LGND
Conviction 81HealthcareScan · Mon, Jul 20, 2026Bearish engulfing
LGND$294.07-3.07%
ResistanceSupportVol 14Insider sellCongress buyCongress sell7
12
Vol MA14 423.04K
Apr 20May 6May 26Jun 11Jul 1Jul 20
Price294.07
Change-3.07%
Gap+1.46%
Rel volume1.07×
Avg volume604.53K
Avg $ vol180.52M
SMA 20304.08
SMA 50261.76
SMA 200215.00
Price vs 50+12.34%
Price vs 200+36.78%
MA stackbullish
50/200 cross—
Supertrendup · 283.22
RSI (14)52
MACD hist-4.70
MACD crossbear · 5d
Stoch %K / %D11 / 24
ADX (14)24
+DI / −DI19 / 19
RSI divergence—
MACD divergence—
ATR %+4.04%
ADR %4.50%
52w high322.61
52w low131.58
From 52w high-8.85%
Above 52w low+123.49%
New 52w highNo
SqueezeOff
Bollinger width20.19%
%B0.34
Donchian pos60.11%
Donchian high326.63
Donchian low245.00
AVWAP (52w high)306.86
vs AVWAP high-4.17%
AVWAP (52w low)215.35
vs AVWAP low+36.55%
OBV trendUp
Chaikin MF (20)0.27
Today vs 20d1.07×
Avg vol (14d)423.04K
Avg vol (20d)604.53K
Avg $ vol (20d)180.52M
Market cap5.89B
RS 3m (vs SPY)+29.97%
RS 6m (vs SPY)+46.70%
RS line new highNo
Trend template8/8
Technical rank87.9
1 week-4.91%
1 month+11.75%
3 months+26.85%
6 months+49.97%
1 year+113.76%
YTD+54.68%
P/E47.35
P/B5.91
P/S21.98
P/FCF120.50
EPS6.13
Div yield—
ROE12.48%
ROA8.12%
Debt/Eq0.03
Current21.28
EV/EBITDA77.64
Gross margin—
Net margin46.42%
Rev growth60.40%
EPS growth3186.63%
Price target336.80
Target upside14.53%
Analyst ratingBuy
Institutional115.09%
Ent. value5.81B
Revenue51.72M
Net income-13.35M
Gross profit—
Free cash flow48.91M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out20.04M
Employees47
ListedFri, Nov 25, 1994
Free float18.87M
Float %95.9%
Short interest2.12M
Days to cover2.6d
Short volume63.5%
Squeeze score52 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.67 vs $0.98
Last surprise-168.4% miss
Setup gradeA
Conviction81 / 100
Pattern quality—
Tech rank87.9 / 100
Group rank23 / 100
Status lane—
Setup direction—
Pattern family
Resistance—
Support—
Days since event—
Candle confirmBearish engulfing
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in LGND · 2 recent
Insider activity
SEC Form 4 transactions in LGND · 6 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Sabba Stephen L Director · Common Stock · 2026-06-16 | Exercise | 2.15K | $142K | 2026-06-16 | 2026-06-18 |
Sabba Stephen L Director · Non-Qualified Stock Option (right to buy) · 2026-06-16 | Exercise | 2.15K | — | 2026-06-16 | 2026-06-18 |
Sabba Stephen L Director · Common Stock · 2026-06-16 | Sell | 2.15K | $545K | 2026-06-16 | 2026-06-18 |
Aryeh Jason Director · Common Stock · 2026-06-11 | Sell | 4.5K | $1.1M | 2026-06-11 | 2026-06-12 |
Aryeh Jason Director · Common Stock · 2026-06-10 | Sell | 500 | $125K | 2026-06-10 | 2026-06-12 |
Aryeh Jason Director · Non-Qualified Stock Option (right to buy) · 2026-06-05 | Grant | 2.94K | — | 2026-06-05 | 2026-06-12 |
Aryeh Jason Director · Common Stock · 2026-06-05 | Grant | 836 | — | 2026-06-05 | 2026-06-12 |
LAMATTINA JOHN L Director · Non-Qualified Stock Option (right to buy) · 2026-06-05 | Grant | 2.94K | $0 | 2026-06-05 | 2026-06-09 |
KOZARICH JOHN W Director · Common Stock · 2026-06-05 | Grant | 836 | $0 | 2026-06-05 | 2026-06-09 |
LAMATTINA JOHN L Director · Common Stock · 2026-06-05 | Grant | 836 | $0 | 2026-06-05 | 2026-06-09 |
SEC filings
EDGAR filings in LGND · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.